Levitra

Active Ingredient

Levitra contains the active ingredient vardenafil. This phosphodiesterase type 5 (PDE5) inhibitor works by increasing blood flow to the penis to help achieve and maintain an erection. Specifically, it helps relax muscles found in the walls of blood vessels and improves blood flow in particular areas of the body. Vardenafil targets PDE5 found in the penis and lungs.

Available Dosage Forms

Levitra is available in tablet form, commonly in doses of 2.5mg, 5mg, 10mg, and 20mg. The tablets are to be taken orally, approximately 60 minutes before sexual activity. Users should adhere to prescribed dosages, as variations could lead to severe side effects or reduced efficacy. Do not split or crush the tablets; swallow them whole with water.

Mechanism of Action

Vardenafil inhibits the PDE5 enzyme, responsible for breaking down cGMP in the penis and lungs. Elevated cGMP levels result in smooth muscle relaxation and the dilation of blood vessels. The increased blood flow thus leads to an erection in response to sexual stimulation. Levitra does not work in the absence of sexual arousal.

Pharmacokinetic Properties

Levitra is rapidly absorbed after oral administration; peak plasma concentrations are reached within 60 minutes. The drug’s absolute bioavailability is approximately 15%. Levitra is metabolized primarily by the liver enzyme CYP3A4, with contributions from CYP3A5 and CYP2C. The half-life of vardenafil is around 4-5 hours, facilitating a duration of action sufficient for most patients.

Clinical Indications

Levitra is indicated for the treatment of erectile dysfunction (ED) in men. It is specifically effective for patients who have difficulties in achieving or maintaining an erection adequate for satisfactory sexual performance. Treatment with Levitra should be initiated in patients who fail to respond to simpler lifestyle changes and other non-pharmacological interventions.

Recommended Dosing

The usual starting dose is 10mg, taken as needed about 60 minutes before sexual activity. Based on efficacy and tolerability, the dose may be increased to a maximum of 20mg or decreased to 5mg. It is advised not to exceed one dose per day. Special population dosing adjustments may be necessary for elderly patients and those with renal or hepatic impairment.

Drug Interactions

Interaction with nitrates can cause severe hypotension and is contraindicated. Levitra should not be co-administered with alpha-blockers due to potential symptomatic hypotension. Concomitant use with strong CYP3A4 inhibitors, such as ketoconazole and ritonavir, may raise vardenafil plasma levels leading to increased risk of adverse effects. Grapefruit juice may increase vardenafil plasma concentrations and should be avoided.

Special Populations

Adjustments may be needed for elderly patients due to decreased metabolic activity. Patients with moderate to severe hepatic impairment should begin with a lower dose and monitor for efficacy and side effects. The pharmacokinetics of Levitra are significantly altered in patients with severe renal impairment, and caution is advised.

Storage Instructions

Store Levitra tablets at room temperature, between 20°C to 25°C (68°F to 77°F). Keep them in their original packaging, away from moisture and light. Keep out of reach of children and pets. Do not store in the bathroom, and discard any expired or no longer needed medication in accordance with local regulations.

Common Adverse Effects

The most frequently reported side effects include headache, flushing, nasal congestion, dyspepsia, and dizziness. A mild and transient bluish vision tint might also occur. These effects are generally mild to moderate in severity and decrease with continued use. Patients should report persistent or troublesome side effects to their healthcare provider.

Serious Adverse Effects

Serious adverse effects include sudden hearing loss, priapism (prolonged and painful erection lasting more than 4 hours), and myocardial infarction. Immediate medical intervention is warranted for these conditions. Use caution in patients with pre-existing cardiovascular conditions as vardenafil can exacerbate these issues.

Contraindications

Levitra is contraindicated in individuals with known hypersensitivity to vardenafil or any component of the tablet. It should not be used in conjunction with nitrates or nitric oxide donors due to the risk of severe hypotension. Individuals with congenital QT interval prolongation and those on antiarrhythmic medications should also avoid Levitra.

Monitoring Parameters

Monitor for efficacy and tolerability, particularly during initial dosing. Blood pressure should be checked to detect hypotension. Electrocardiogram (ECG) monitoring may be recommended in patients with pre-existing heart conditions. Regular follow-up with healthcare providers is advised to reassess the need for ongoing treatment and possible dose adjustments.

Patient Counseling Information

Instruct patients to take Levitra exactly as prescribed and emphasize the importance of adhering to dietary and timing recommendations for optimal efficacy. Educate on the potential side effects and the need to seek immediate medical attention for serious adverse reactions. Advise patients not to use other PDE5 inhibitors concurrently and to avoid excessive alcohol intake.

Clinical Studies

Clinical trials have demonstrated Levitra’s high efficacy in improving erectile function in a wide range of populations, including those with diabetes mellitus and post-prostatectomy. Studies have shown a significant improvement in the International Index of Erectile Function (IIEF) scores among users. Comparative studies indicate that vardenafil is effective even in patients who did not respond well to other ED treatments.

Administration Guidelines

Administer Levitra orally with or without food; however, a high-fat meal may delay the onset of action. Swallow the tablet whole with a glass of water, and avoid splitting or chewing. Patients should take the tablet approximately 60 minutes before planned sexual activity and not exceed one dose per 24-hour period. Follow up with patients to assess efficacy and any need for dosage adjustments.